Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).

HIZAL, MUTLU; ŞENDUR, MEHMET; YAŞAR, HATİME; Bir Yucel, KADRİYE; Arslan, Cagatay; Ucar, Gokhan; Karakaya, Serdar; Taban, Hakan; Kucukarda, Ahmet; Erturk, Ismail; Bilgin, Burak; Yildirim, Nuriye; Demirci, Umut; KILIÇKAP, SAADETTİN; ÇİÇİN, İRFAN; Karadurmus, Nuri; YALÇIN, BÜLENT; ÜRÜN, YÜKSEL

doi:10.1177/1078155219900908

Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).

HIZAL M., ŞENDUR M. A. N., YAŞAR H. A., Bir Yucel K., Arslan C., Ucar G., ...More

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, vol.26, no.7, pp.1583-1589, 2020 (SCI-Expanded)

Publication Type: Article / Article
Volume: 26 Issue: 7
Publication Date: 2020
Doi Number: 10.1177/1078155219900908
Journal Name: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
Page Numbers: pp.1583-1589
Keywords: Interferon, neutrophil-lymphocyte ratio, prognosis, renal cell cancer, tyrosine kinase inhibitors, PRETREATMENT NEUTROPHIL, INFLAMMATION, CANCER, IMPACT, PROGRESSION, VALIDATION
Gazi University Affiliated: Yes

Abstract

Background